The Boston Scientific Acurate neo self-expanding TAVR valve (left) did not perform as well clinically as the Medtronic CoreValve Evolut TAVR valve (right) in the SCOPE II trial presented at TCT 2020. #TCT #TCT2020 #TCTconnect

October 15, 2020 – The SCOPE II trial comparing the Boston Scientific Acurate neo vs. Medtronic CoreValve Evolut TAVR valves found the Acurate Neo failed to demonstrate non-inferiority compared to the existing self-expanding valve. This was the same negative result as the SCOPE I trial presented at TCT 2019, where a comparison with the Acurate Neo vs. Sapien also did not meet non-inferiority.[1]

October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral valve repair (TMVR) was not superior to conservative medical treatment with regard to the primary endpoint of change in six minute walking distance.

October 14, 2020 — American College of Cardiology (ACC) Quality Summit virtual meeting Oct. 8-9, 2020, featured several poster presentations on COVID-19 impacts within cardiology practice over the last several months.

October 14, 2020 — The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) are partnering to create the Martin B. Leon Center for Cardiovascular Transformation, a visionary endeavor designed to foster the best ideas, encourage innovative research, and ultimately deliver transformative solutions to some of the biggest cardiovascular care challenges.

October 14, 2020 — Medtronic announced it is starting a randomized, head-to-head study comparing two transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS). The SMall Annuli Randomized To Evolut or Sapien (SMART) post-market trial will compare valve safety and performance of the self-expanding Medtronic CoreValve Evolut Pro and Pro+TAVR Systems against the balloon-expandable Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valves manufactured by Edwards Lifesciences.

October 14, 2020 – The first outcomes data from the North American COVID-19 ST-Segment Elevation Myocardial Infarction (NACMI) Registry are being presented today at the 2020 virtual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium.

Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.

This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail in the two-volume set titled "Emerging Technologies in Heart Diseases." These innovative technologies mark the midway of a technological revolution in patient care. Here are a list of 10 noteworthy new cardiac technologies:
The Philips Lumify point-of-care ultrasound (POCUS) system uses an app and a transducer to convert a smartphone into a portable ultrasound system. Philips and GE Healthcare both offer small hand-held systems and are now facing increased competition from new POCUS vendors like Butterfly Network.

For all the changes in medicine there are some things that seem resolutely stable. Chief among these is the idea that sick people go to doctors’ surgeries or hospitals to be diagnosed and treated. This, the simplest of healthcare tenets, could however begin to be challenged, as one area of imaging, ultrasound, begins to be freed. This is the view of healthcare technology research firm Signify Reseach.

October 8, 2020 — Galaxy Medical, a developer of pulsed electric field (PEF) technology for the treatment of cardiac arrhythmias, announced the first patients in the ECLIPSE-AF study were successfully treated with the proprietary Centauri System by Dr. Ante Anić in Split, Croatia. This multicenter trial is designed to assess the safety and efficacy of the Centauri System and is intended to support European CE-mark clearance. 

October 8, 2020 – Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system.

Using ultrasound-on-chip technology, the Butterfly iQ+ offers new capabilities, such as faster frame rates, Needle Viz technology, a longer battery life and improved durability. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now